- Home
- ASYS vs INMB Comparison
ASYS vs INMB Comparison
Compare ASYS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- INMB
- Stock Information
- Founded
- ASYS 1981
- INMB 2015
- Country
- ASYS United States
- INMB United States
- Employees
- ASYS N/A
- INMB N/A
- Industry
- ASYS Industrial Machinery/Components
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- INMB Health Care
- Exchange
- ASYS Nasdaq
- INMB Nasdaq
- Market Cap
- ASYS 59.4M
- INMB 68.9M
- IPO Year
- ASYS N/A
- INMB 2019
- Fundamental
- Price
- ASYS $4.81
- INMB $2.31
- Analyst Decision
- ASYS
- INMB Buy
- Analyst Count
- ASYS 0
- INMB 4
- Target Price
- ASYS N/A
- INMB $9.53
- AVG Volume (30 Days)
- ASYS 40.9K
- INMB 6.9M
- Earning Date
- ASYS 08-06-2025
- INMB 07-31-2025
- Dividend Yield
- ASYS N/A
- INMB N/A
- EPS Growth
- ASYS N/A
- INMB N/A
- EPS
- ASYS N/A
- INMB N/A
- Revenue
- ASYS $90,826,000.00
- INMB $50,000.00
- Revenue This Year
- ASYS N/A
- INMB $82.14
- Revenue Next Year
- ASYS $28.60
- INMB $28,750.98
- P/E Ratio
- ASYS N/A
- INMB N/A
- Revenue Growth
- ASYS N/A
- INMB N/A
- 52 Week Low
- ASYS $3.20
- INMB $1.89
- 52 Week High
- ASYS $6.96
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- ASYS 65.20
- INMB 26.84
- Support Level
- ASYS $4.66
- INMB $2.22
- Resistance Level
- ASYS $4.94
- INMB $2.49
- Average True Range (ATR)
- ASYS 0.25
- INMB 0.94
- MACD
- ASYS 0.04
- INMB -0.24
- Stochastic Oscillator
- ASYS 86.14
- INMB 4.31
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.